21 January, 2019

Marketing of opioid products to physicians was associated with increased opioid prescribing and, subsequently, with elevated mortality from overdoses, finds a new US study. Amid a national opioid overdose crisis, reexamining the influence of the pharmaceutical industry may be warranted.


No comments: